BOOK
Breast MRI, An Issue of Magnetic Resonance Imaging Clinics - E-Book
Linda Moy | Cecilia L. Mercado
(2010)
Additional Information
Book Details
Abstract
This publication presents topics on Current Clinical Indications for Breast MRI; How to set up breast MRI practice; MR-BIRADS Lexicon; Optimization of breast MRI at 1.5 Tesla(T) and at 3 Tesla; Role of MRI in evaluating extent of disease; Update on Screening breast MRI in high risk women; MRI of DCIS; Role of breast MRI in the assessment of Invasive lobular carcinoma; Breast MRI Interventions: Indications, Technique, and Histologic Correlation; Role of Breast MRI in problem-solving; Benign lesions detected on breast MRI; Clinical Oncologic Perspective of Breast MRI; Role of breast MRI in neo-adjuvant chemotherapy.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | v | ||
| Contents | vii | ||
| Preface | xiii | ||
| Chapter 1. Breast Magnetic\r\nResonance Imaging:\r\nCurrent Clinical\r\nIndications | 155 | ||
| SCREENING FOR THE HIGH-RISK PATIENT | 156 | ||
| SCREENING FOR THE CONTRALATERAL BREAST | 159 | ||
| IMPLANTS AND BREAST AUGMENTATION | 159 | ||
| EXTENT OF DISEASE | 160 | ||
| FOLLOWING NEOADJUVANT CHEMOTHERAPY | 162 | ||
| EVALUATION FOR RECURRENCE OF BREAST CANCER | 163 | ||
| METASTATIC CANCER OF UNKNOWN PRIMARY AND AXILLARY ADENOPATHY | 164 | ||
| PROBLEM SOLVING | 166 | ||
| MR PROCEDURE GUIDANCE | 167 | ||
| SUMMARY | 167 | ||
| REFERENCES | 167 | ||
| Chapter 2. The BI-RADS Breast Magnetic Resonance Imaging Lexicon | 171 | ||
| KINETIC EVALUATION | 171 | ||
| BACKGROUND ENHANCEMENT | 172 | ||
| MORPHOLOGIC EVALUATION | 174 | ||
| PROBABLY BENIGN LESIONS | 183 | ||
| ASSOCIATED FINDINGS | 184 | ||
| SUMMARY | 184 | ||
| REFERENCES | 184 | ||
| Chapter 3. Implementing a Breast MR Imaging Program: All Things Considered | 187 | ||
| AMERICAN COLLEGE OF RADIOLOGY BI-RADS LEXICON | 187 | ||
| INDICATIONS FOR BREAST MR IMAGING | 187 | ||
| MAGNET SELECTION | 188 | ||
| SELECTING MAGNET STRENGTH | 189 | ||
| INSTALLATION AND IMAGING READINESS | 191 | ||
| REFERRAL BASE | 192 | ||
| HANDLING BREAST MR IMAGING REQUESTS | 193 | ||
| SCHEDULING BREAST MR IMAGING | 193 | ||
| EXAMINATION PERFORMANCE | 193 | ||
| BREAST MR IMAGING INTERPRETATION | 194 | ||
| BACKGROUND PATIENT DATA | 194 | ||
| CORRELATIVE BREAST IMAGING | 195 | ||
| REPORTING | 195 | ||
| REPORT TEMPLATES | 195 | ||
| COMMUNICATION OF RESULTS | 196 | ||
| SUMMARY | 196 | ||
| ACKNOWLEDGMENTS | 196 | ||
| REFERENCES | 196 | ||
| Chapter 4. Role of Magnetic Resonance Imaging in Evaluating the Extent of Disease | 199 | ||
| PITFALLS OF MRI STAGING OF BREAST CANCER | 200 | ||
| IMPACT OF PREOPERATIVE BREAST MRI ON CLINICAL MANAGEMENT | 202 | ||
| PREOPERATIVE STAGING WITH BREAST MRI—CURRENT CONTROVERSIES | 202 | ||
| CONTRALATERAL BREAST CANCER SCREENING—CURRENT DISCUSSION | 203 | ||
| WHAT OF IMPACT ON LOCAL RECURRENCE AND OVERALL SURVIVAL? | 203 | ||
| MRI DETECTION AND STAGING OF BREAST CANCER: WHAT QUESTIONS REMAIN? | 204 | ||
| SUMMARY | 204 | ||
| REFERENCES | 204 | ||
| Chapter 5. Optimizing 1.5-Tesla and 3-Tesla Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Breasts | 207 | ||
| PATIENT FACTORS | 208 | ||
| EQUIPMENT: MAGNET AND COIL | 208 | ||
| PITFALLS AND TECHNICAL ARTIFACTS | 210 | ||
| IMAGING PROTOCOL | 211 | ||
| CONTRAST MEDIUM | 213 | ||
| SPATIAL VERSUS TEMPORAL RESOLUTION | 214 | ||
| IMAGING PLANE | 215 | ||
| WHY MOVE TO BREAST MR IMAGING AT 3T? | 215 | ||
| TECHNICAL CONSIDERATIONS FOR OPTIMIZING IMAGE QUALITY AT 3T | 216 | ||
| RF HOMOGENEITY | 216 | ||
| MR IMAGING ARTIFACTS | 217 | ||
| FUTURE MR IMAGING PROTOCOLS AT 3T | 217 | ||
| CHALLENGES AT 3T | 217 | ||
| SPECIFIC ABSORPTION RATE | 218 | ||
| MEDICAL DEVICES | 219 | ||
| ADDITIONAL APPLICATIONS OF THE 3T MAGNETS | 219 | ||
| SUMMARY | 221 | ||
| REFERENCES | 222 | ||
| Chapter 6. MR Imaging of Ductal Carcinoma In Situ | 225 | ||
| BIOLOGY OF DCIS | 226 | ||
| MR IMAGING CHARACTERISTICS OF DCIS | 227 | ||
| MR IMAGING TECHNIQUE | 228 | ||
| MR IMAGING APPEARANCE OF DCIS | 229 | ||
| DISTRIBUTION OF NMLE | 229 | ||
| INTERNAL ENHANCEMENT PATTERNS OF NMLE | 230 | ||
| KINETIC PATTERNS | 234 | ||
| INTERPRETATION CHALLENGES | 234 | ||
| COMPUTER-AIDED DIAGNOSIS | 234 | ||
| IMPACT ON PATIENT MANAGEMENT | 235 | ||
| FUTURE RESEARCH: HIGH TEMPORAL RESOLUTION IMAGING | 235 | ||
| FUTURE RESEARCH: MOUSE MODELS OF DCIS | 236 | ||
| SUMMARY | 237 | ||
| REFERENCES | 237 | ||
| Chapter 7. Update on Screening Breast MRI in High-Risk Women | 241 | ||
| GENETIC COUNSELING | 241 | ||
| INDICATIONS FOR PERFORMING MRI SCREENING | 242 | ||
| BRCA1 AND -2 MUTATION CARRIERS | 242 | ||
| SPORADIC HEREDITARY BREAST CANCER SYNDROMES | 242 | ||
| INDIVIDUAL INCREASED RISK | 243 | ||
| TREATMENT OPTIONS | 244 | ||
| RESULTS OF SCREENING | 244 | ||
| SUMMARY | 246 | ||
| REFERENCES | 246 | ||
| Chapter 8. Role of Breast MR Imaging in Neoadjuvant Chemotherapy | 249 | ||
| MR IMAGING | 250 | ||
| MR IMAGING ASSESSMENT OF TUMOR SIZE | 250 | ||
| MR IMAGING ASSESSMENT OF TUMOR ENHANCEMENT | 253 | ||
| FUNCTIONAL MR IMAGING ASSESSMENT | 253 | ||
| FUNCTIONAL MR IMAGING ASSESSMENT: SPECTROSCOPY | 254 | ||
| FUNCTIONAL MR IMAGING ASSESSMENT: DIFFUSION-WEIGHTED MR IMAGING | 256 | ||
| SUMMARY | 256 | ||
| REFERENCES | 256 | ||
| Chapter 9. The Effectiveness of MR Imaging in the Assessment of Invasive Lobular Carcinoma of the Breast | 259 | ||
| CONVENTIONAL IMAGING METHODS IN ILC | 261 | ||
| FEATURES OF ILC ON BREAST MR IMAGING | 263 | ||
| AGREEMENT OF MR IMAGING FINDINGS WITH PATHOLOGIC ASSESSMENT OF ILC | 265 | ||
| CONSEQUENCES FOR THE THERAPEUTIC APPROACH OF ILC | 267 | ||
| EFFECT OF PREOPERATIVE BREAST MR IMAGING ON OUTCOME IN PATIENTS WITH ILC | 269 | ||
| EVALUATION OF THE CONTRALATERAL BREAST WITH MR IMAGING IN PATIENTS WITH ILC | 271 | ||
| CURRENT EVIDENCE FOR THE PERFORMANCE OF BREAST MR IMAGING IN ILC, SHORTCOMINGS, AND FUTURE PERSPECTIVES | 272 | ||
| REFERENCES | 272 | ||
| Chapter 10. A Clinical Oncologic Perspective on Breast Magnetic Resonance Imaging | 277 | ||
| MR IMAGING FOR TREATMENT SELECTION | 278 | ||
| THE EFFECT OF MR IMAGING ON SHORT-TERM SURGICAL OUTCOMES | 279 | ||
| EFFECT OF MR IMAGING ON LONG-TERM CANCER OUTCOMES | 282 | ||
| MR IMAGING FOR OCCULT BREAST CANCER | 284 | ||
| MR IMAGING TO SELECT PATIENTS FOR ACCELERATED PARTIAL BREAST IRRADIATION | 285 | ||
| MR IMAGING–NEOADJUVANT CHEMOTHERAPY | 286 | ||
| MR IMAGING FOR DETECTION OF LOCAL RECURRENCE | 288 | ||
| SUMMARY | 290 | ||
| REFERENCES | 290 | ||
| Chapter 11. MR Imaging in the Evaluation of Equivocal Clinical and Imaging Findings of the Breast | 295 | ||
| CLINICAL SYMPTOMS | 296 | ||
| LIMITATIONS | 305 | ||
| SUMMARY | 305 | ||
| REFERENCES | 305 | ||
| Chatper 12. Probably Benign Lesions Detected on Breast MR Imaging | 309 | ||
| INCIDENCE OF MR IMAGING BI-RADS 3 | 310 | ||
| CANCER YIELD OF BI-RADS 3 | 311 | ||
| LESION FEATURES | 313 | ||
| TIMING OF SHORT-INTERVAL FOLLOW-UP | 318 | ||
| FOLLOW-UP COMPLIANCE | 318 | ||
| SUMMARY | 318 | ||
| REFERENCES | 320 | ||
| Chapter 13. MR Intervention: Indications, Technique, Correlation and Histologic | 323 | ||
| INDICATIONS FOR INTERVENTIONAL MR | 323 | ||
| MR-GUIDED BIOPSY TECHNIQUE | 326 | ||
| HISTOLOGY CORRELATION | 329 | ||
| REFERENCES | 331 | ||
| Index | 333 |